| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
211,603.82 | 196,541.82 | 194,489.99 | 191,500.95 | 193,962.36 |
| Cost of Revenue
|
-126,787.97 | -119,131.97 | -118,139.17 | -119,290.71 | -130,403.57 |
|
Gross Profit
|
84,815.85 | 77,409.85 | 76,350.82 | 72,210.24 | 63,558.79 |
|
Selling, General and Administrative Expenses
|
-70,334.33 | -62,685.33 | -62,210.88 | -59,021.62 | -57,285.48 |
|
Operating Income/Expenses
|
-70,334.33 | -62,685.33 | -62,210.88 | -59,021.62 | -57,285.48 |
|
Total Operating Profit/Loss
|
14,481.51 | 14,724.51 | 14,139.94 | 13,188.62 | 6,273.30 |
| Total Net Finance Income/Expense
|
-1,777.92 | -1,559.92 | -1,942.64 | -2,977.16 | -2,364.46 |
| Irregular Income/Expenses
|
0 | -- | 0 | 12,564.15 | 0 |
|
Other Income/Expense, Non-Operating
|
-247.97 | -46.97 | 95.11 | -41 | -246.40 |
|
Non-Operating Income/Expenses, Total
|
-2,025.89 | -1,606.89 | -1,847.53 | 9,545.99 | -2,610.86 |
|
Pretax Income
|
12,455.62 | 13,117.62 | 12,292.41 | 22,734.60 | 3,662.45 |
|
Provision for Income Tax
|
-2,642.20 | -2,933.20 | -2,270.06 | -4,941.44 | -627.68 |
|
Net Income from Continuing Operations
|
9,813.42 | 10,184.42 | 10,022.35 | 17,793.16 | 3,034.77 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
9,813.42 | 10,184.42 | 10,022.35 | 17,793.16 | 3,034.77 |
|
Net Income after Non-Controlling/Minority Interests
|
9,813.42 | 10,184.42 | 10,022.35 | 17,793.16 | 3,034.77 |
|
Net Income Available to Common Stockholders
|
9,813.42 | 10,184.42 | 10,022.35 | 17,793.16 | 3,034.77 |
|
Diluted Net Income Available to Common Stockholders
|
9,813.42 | 10,184.42 | 10,022.35 | 17,793.16 | 3,034.77 |
|
Common Dividend per Share
|
0.48 | -- | -- | -- | -- |
| Basic EPS
|
2.57 | 2.69 | 2.71 | 4.98 | 0.86 |
| Diluted EPS
|
2.38 | 2.49 | 2.45 | 4.86 | 0.82 |
|
Basic Weighted Average Shares Outstanding
|
3,808.78 | 3,787.28 | 3,700.57 | 3,572.14 | 3,527.63 |
|
Diluted Weighted Average Shares Outstanding
|
4,121.08 | 4,087.08 | 4,098.55 | 3,657.70 | 3,719.25 |
|
Reported Normalized Basic EPS
|
2.71 | -- | 2.71 | 2.28 | -- |
|
Reported Normalized Diluted EPS
|
2.45 | -- | 2.45 | 2.23 | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
14,233.54 | 14,677.54 | 14,235.05 | 25,711.77 | 6,026.91 |
|
EBITDA
|
21,474.26 | 21,024.26 | 20,304.28 | 30,779.36 | 10,604.69 |
|
Normalized EBITDA
|
23,370.01 | 23,018.01 | 22,487.28 | 20,155.65 | 12,407.99 |
|
Normalized Income
|
11,307.03 | 11,731.58 | 11,812.41 | 9,506.67 | 4,531.51 |
|
Total Unusual Items
|
1,895.76 | 1,993.76 | 2,183 | -10,623.71 | 1,803.30 |
12/31/2022 - 3/17/1980
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade
